Toggle navigation
TWunroll
TWunroll
faq
Contact US
Kert Viele
KertViele
(1/n) We often see related datasets (multiple vaccine trials, multiple trials exploring the amyloid hypothesis in Alzheimer’s, basket trials in oncology) How do we think about multiple groups of data
Read more
(1/n) A few weeks ago I noted that if you expecting vaccine efficacies in the 30-70% range, knowing an interim says “continue” doesn’t say much. With Pfizer’s very optimistic 90%,
Read more
(1/n) On disclosure, what a sponsor needs to know, how the choice of design has a huge impact on that, and how we might create a new system in the
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree